DOCSLIB.ORG

Saudiarabia Borrows$10Bn Asoilslump

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Saudiarabia Borrows$10Bn Asoilslump WEDNESDAY 20 APRIL 2016 WORLDBUSINESSNEWSPAPER UK £2.70 Channel Islands £3.00; Republic of Ireland €3.00 Martin Wolf China uncorked Pay grades Brexit is a perilous one-way bet HowChileischallengingFranceinthe Students need more data on college for Britain —COMMENT, PAGE 11 Chinese wine market —BIG READ, PAGE 9 performance —SARAH O’CONNOR, PAGE 12 No more tears Millennial mums going Saudi Arabia Briefing ga-ga for organics spark J&J rethink i EDF board warned over Hinkley Point Managers at the French utility have written to its board warning that the directors could be held responsible if the company pushes on with its borrows $10bn £18bn nuclear project.— PAGE 15; ANALYSIS, PAGE 17 i Hammond rules out Libya combat role The foreign secretary has told MPs that there are no plans for troops to be involved in fighting Isis in as oil slump Libya, though the UK was willing to send thousands to help train “unity” government forces.— PAGE 4 i Extremist allegations threaten Khan bid Former human rights lawyer and drains reserves Labour candidate for London mayor Sadiq Khan leads the polls but questions, pushed by Tory rival Zac Goldsmith, on links to extremists may 3 First debt-raising since 1991 be hurting his campaign.— PAGE 4 3 Move paves way for historic bond i Labour shortage to drive US wages A leading business group has predicted that the US SIMEONKERR —DUBAI “This is paving the way for the king- faces significant labour shortages in a wide range of ELAINEMOORE — LONDON domtotransformfromacreditornation sectors as unemployment falls towards 4 per cent Saudi Arabia is raising $10bn from a into a debtor nation. It’s a significant and the working-age population stagnates.— PAGE 5 consortium of global banks as the king- momentofchangeindebtmarkets.” dom embarks on its first international Saudi Arabia may now raise its first i Goldman profit plunge caps grim season borrowing in 25 years to counter dwin- global bond in the wake of the loan deal, The US bank’s profits have more than halved after dlingoilrevenuesandreserves. bankers said. Institutions that loaned across-the-board falls in revenues, bringing down Thelandmarkfive-yearloan,asignof the most would be set to benefit from a the curtain on a sobering earnings season for the big Riyadh’s newfound dependence on mandatetohelpRiyadhraisethebond. US banks.— PAGE 15; LEX, PAGE 14; ANALYSIS, PAGE 16 foreign capital, opens the way for the The lead lenders, each pledging about country to launch its first international $1.3bn, include Bank of Tokyo-Mitsubi- i Saudis host Obama and look to successor bond issue. It comes as the low price of shi, HSBC and JPMorgan, bankers said. The US president arrives in Riyadh today, where he crude encourages other Gulf govern- Banks were required to lend at least will be greeted by hosts looking past the US election ments, such as Abu Dhabi, Qatar and $500mtoparticipate. in the hope his successor will restore ties that have Oman,totapbondmarkets. Mr Algaseer declined to comment on frayed during his time in office.— PAGE 7 The oil-rich kingdom, which last the pricing but other bankers close to weekend blocked a deal among oil pro- the deal said it had priced at around i Tesco Bank targets mortgage market ducers to freeze output and bolster 120basispointsoverUSdollarLibor. The Edinburgh-based lender has unveiled a push to prices, has burnt through about $120bn The loan is Saudi Arabia’s first inter- take on the high-street banks by offering property inreservessincelate2014.Itsfiscaldefi- national borrowing since 1991, when it loans through independent brokers, a sign that cit is set to widen to 19 per cent of gross raised about $1bn in the aftermath of mortgage market competition is rising.— PAGE 20 domesticproductthisyear. theIraqiinvasionofKuwait. Strong interest in the loan, especially Bankers are now confident that Saudi fromAsia,camedespiteratingagencies’ state-relatedcompanieswillalsoseekto A Johnson & Johnson US magazine advertisement from the 1950s — Image courtesy of the Advertising Archive downgrades on Saudi creditworthiness raise funds, using the sovereign loan, Datawatch since the oil price collapsed. The gov- andlaterbond,asabenchmark. ernment raised the amount it wanted to Prince Mohammed bin Salman, who DAVID CROW — NEW YORK changingtastesofyoungercon- to rethink their strategies as Employment rates in The last quarter — CHICAGO borrow from $6bn-$8bn to $10bn after oversees economic reform, is set to LINDSAY WHIPP sumers. US sales of J&J’s baby they struggle to cope with the the OECD of 2015 saw the thedealwasoversubscribed. publish his “vision for Saudi Arabia”, a care products, including its “no shiftingtastesofmillennials. 15-64 year olds (%) proportion of Johnson & Johnson is 66.5 “Thedealisverysuccessful,withvery template for shifting to a post-oil era, in relaunching its baby care busi- more tears” shampoo, fell Mr Caruso said J&J had people in jobs in the OECD area competitive pricing,” said Elyas Algas- RiyadhonApril25. ness because millennial moth- 14 per cent year-on-year in the “robust plans to relaunch 66.0 eer,deputy regional general manager at It is expected to give details about the first quarter to $95m, their baby”thisyear. return to the peak ers are ditching its talcum 65.5 level hit in the Bank of Tokyo-Mitsubishi. “There was privatisation of state oil company Saudi powders and shampoos in lowestlevelinadecade. The company’sinfant brands 65.0 first quarter of immensemarketappetite.” Aramco, the creation of a sovereign favour of more expensive “It looks like millennial have been a mainstay since the 2008. However, Ewen Cameron Watt, chief invest- wealth fund and other reforms to boost organicalternatives. moms are buying new organic launch of Johnson’s baby pow- 64.5 employment rates ment strategist at BlackRock, the jobs and investment. JPMorgan has products,” said Dominic der in 1893. But more recently 64.0 are not back to world’slargestassetmanager,said:“The been working with the state oil com- Tumbling sales of its baby care Caruso,chieffinancialofficer. the company has struggled to pre-crisis levels in loan is a way for Saudi Arabia to test the pany since late last year on a plan for an products have forced the Brands from McDonald’s, combat the perception that 2006 10 15 many countries, waters and set up an international initial public offering, people aware of change, making J&J the latest Heinz and Campbell’s Soup to some of its products contain Source: OECD including the US borrowingprofile. themattersaid. power brand to fall prey to the Avon andGaphavebeenforced dangerouschemicals. Gove holds up Albanian model for post-Brexit future outside EU market GEORGE PARKER — LONDON Critics seized on Mr Gove’s “Albanian saying the UK should not accept the ALEX BARKER —BRUSSELS model”, pointing out that the Balkan principal conditions for entry. It would Britain will move outside the EU’s country has limited access to the single not pay into the EU budget, accept free singlemarketandinsteadjoin“Bosnia, market, no financial services “pass- movement of workers or the jurisdic- Serbia,AlbaniaandUkraine”inaEuro- ports” and its exports to the EU are sub- tionoftheEuropeanCourtofJustice. Mistrust of Spain keeps EU pean free trade zone if voters choose jecttocustomschecks. The “free-trade area” described by support solid in Gibraltar Brexit in June’s referendum, according Brexit campaigners were challenged Mr Gove takes several forms. Iceland, toavisionoutlinedbyMichaelGove. byGeorgeOsborneonMondaytosetout Liechtenstein, Norway and Switzerland Gibraltar, ceded to Britain in the 1713 exactly what “Out” would look like. are part of the European Free Trade Treaty of Utrecht but seen by Spain as The pro-Brexit justice secretary for the Mr Gove set out to respond, saying: Association,whosemembershavevary- a colonial relic that sooner or later will first time confirmed yesterday that the “There is a free-trade zone stretching ing levels of single market access. Nor- be returned, wants the UK to stay in Leave camp did not want Britain to from Iceland to Turkey that all Euro- waypaysintotheEUbudgetandaccepts the EU. A poll puts support at 88 per remainpartoftheEU’stariff-freeblocin peannationshaveaccessto . free movement. Switzerland does not cent amid fears that should Britain which British-based banks can trade “After we vote to leave we will remain have full access to the single market but leave, ‘Spain might be tempted to be under a “passport” scheme. He insisted in the zone. The suggestion that Bosnia, doesacceptfreemovement. mischievous at best and downright the UK’sfinancial services sector would Serbia, Albania and Ukraine would Albania has an agreement covering vindictive at worst’, especially with “thrive”inthisnewenvironment. remain part of this free-trade area — trade in goods and potentially financial regard to its border crossing, used by He said Britain would forge its own andBritainwouldbeontheoutsidewith services. But it would only have full 30,000 workers and visitors every day. deal with the EU but said that a conti- just Belarus — is as credible as Jean- single-market access if it applies the Analysis i PAGE 2 nent-wide free trade area embracing a ClaudeJunckerjoiningUkip.” existingandfutureEUrulebook. Martin Wolf i PAGE 11 wide range of bilateral deals would “be MrGove’saidessaidBritainwouldnot Britain in Europe pages 2 & 3 thecoreofournewarrangement”. seektoremainpartofthesinglemarket, Martin Wolf page 11 Subscribe In print and online World Markets www.ft.com/subscribenow Tel: 0800 298 4708 STOCK MARKETS CURRENCIES
Load more

Recommended publications
  • Professor Julie Audet<B>
    University of Toronto Faculty, Staff, and Student Awards and Honours Governing Council Meeting October 23, 2008 Faculty & Staff Awards Professor Emeritus Paul Aird of forestry is the winner of the Endangered Species Stewardship Award, presented to him by Donna Cansfield, Ontario minister of natural resources, at a natural History Day event, held May 24 at Bonnechere Provincial Park in Renfrew County. Aird was honoured for his volunteer contributions related to Kirtland’s Warbler over the past 30-plus years, not only raising public awareness for this particular species at risk but for having made an important contribution towards recovery of this globally rare bird in Ontario. Keith Ambachtsheer, director of the Rotman International Centre for Pension Management, is the recipient of the James R. Vertin Award, given by the CFA (chartered financial analyst) Institute to recognize individuals who have produced a body of research notable for its relevance and enduring value to investment professionals. Ambachtsheer received the award July 22 at the 50th Financial Analysts Seminar, a CFA Institute conference hosted by the CFA Society of Chicago. Francesca Andrade of financial services is this year’s winner of U of T Scarborough’s Patrick Phillips Staff Award for outstanding service and commitment by a campus staff member, while Svetlana Mikhaylichenko of physical and environmental sciences is the recipient the D.R. Campbell Merit Award for enhancing the quality of life on campus. Professor Janet Potter of physical and environmental sciences is the winner of the Faculty Teaching Award. The Principal’s Awards were presented in June at an event hosted by Principal Franco Vaccarino.
    [Show full text]
  • 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
    Case 2:16-cv-02373-SPL Document 1 Filed 07/15/16 Page 1 of 36 1 Mark D. Samson Ron Kilgard 2 KELLER ROHRBACK L.L.P. 3 3101 North Central Ave., Suite 1400 Phoenix, AZ 85012 4 Phone: (602) 248-0088, Fax (602) 248-2822 5 [email protected] [email protected] 6 Lynn Lincoln Sarko (pro hac vice application forthcoming) 7 Gretchen Freeman Cappio (pro hac vice application forthcoming) 8 T. David Copley 1201 Third Avenue, Suite 3200 9 KELLER ROHRBACK L.L.P. 10 Seattle, WA 98101-3052 (206) 623-1900, Fax (206) 623-3384 11 [email protected] [email protected] 12 [email protected] 13 Attorneys for Plaintiffs 14 15 UNITED STATES DISTRICT COURT DISTRICT OF ARIZONA 16 R.C., individually and on behalf of all others 17 similarly situated, No. 18 Plaintiff, 19 CLASS ACTION COMPLAINT v. 20 JURY TRIAL DEMANDED THERANOS, INC., a California 21 Corporation, and WALGREENS BOOTS 22 ALLIANCE, INC., a Delaware Corporation, 23 Defendants. 24 25 26 27 COMPLAINT 28 1 Case 2:16-cv-02373-SPL Document 1 Filed 07/15/16 Page 2 of 36 1 I. INTRODUCTION 2 1. Blood tests are a critical component of a patient’s healthcare. Patients, as well as 3 their doctors, rely on blood tests to detect conditions and use those results to help determine which 4 course of treatment is or isn’t needed. Inaccurate blood test results can contribute to serious 5 6 conditions going undetected, to treatable conditions growing worse unnoticed, to patients forgoing 7 medications they should take or taking medications they shouldn’t.
    [Show full text]
  • DRUG DISCOVERY SUMMIT: Enabling Early Stage Drug Discovery and Venture Creation
    PRESENT: DRUG DISCOVERY SUMMIT: Enabling Early Stage Drug Discovery and Venture Creation Event Program JLABS@Toronto Tuesday June 11, 2019 MaRS Centre, West Tower 1:00 – 6:00 PM 661 University Avenue, Suite 1300 Toronto, ON, Canada M5G 0B7 POWERED BY: WELCOME MaRS Innovation and our partner Evotec SE are pleased to welcome you to our inaugural LAB150 Drug Discovery Summit. We would like to thank Allan Miranda and the JLABS team for hosting us here today in this spectacular facility! It has been 18 months since we launched LAB150, a program designed to enable translation of academic discoveries into medicines from MaRS Innovation (MI) Members. With five projects approved and funded and one project graduated from the program and negotiating follow-on investment, we are off to an incredible start! The LAB150 program, paired with MI’s venture creation and investment model, provides a leading platform for life sciences venture creation and growth in Canada. Over the last decade, MI has created over 50 companies that have attracted and retained seasoned management, created over 400 STEM jobs and raised over $350M in direct third-party capital. With LAB150, we look forward to building on this success in the coming decade and beyond. Today you will hear from entrepreneurs and scientists regarding their experiences with the LAB150 program. In addition, we are pleased to be joined by scientific experts from Evotec who will share emerging trends in the drug discovery space. Last but not least, early stage investors will share their tips and tricks for securing capital for building therapeutic ventures in Canada.
    [Show full text]
  • Theranos Phenomenon – Part 5: Theranos’ Presentation at the American Association for Clinical Chemistry Annual Conference 2016
    Clin Chem Lab Med 2016; 54(10): e313–e314 Letter to the Editor Eleftherios P. Diamandis* and Mario Plebani Theranos phenomenon – Part 5: Theranos’ presentation at the American Association for Clinical Chemistry Annual Conference 2016 DOI 10.1515/cclm-2016-0737 Master, two highly recognized and respected clinical Accepted for publication August 18, 2016; previously published chemists, who did a good job in asking pertinent ques- online August 30, 2016 tions to Ms. Holmes and her associates. In this respect, AACC lived up to the expectations of high standards and Keywords: diagnostics; new technologies. impartiality for this presentation. Holmes presented to a large and curious, if not To the Editor, hostile, audience. She avoided talking about Theranos’ past and the difficulties of her company [1–7]. She also The widely anticipated presentation of Theranos at the made it clear that her presentation would focus on the Annual Conference of the American Association for future, not the past, and she distanced herself from the Clinical Chemistry (AACC) was finally given on Monday, previous “Edison” instrument and introduced a new August 1st, 2016 at the Philadelphia Convention Center. analyzer named “MiniLab”. In the first part of her pres- This journal has followed the Theranos story closely over entation, Ms. Holmes described the engineering behind the last 2 years and provided frequent updates [1–4]. Eliza- the MiniLab and explained that it is a compact desktop beth Holmes, the Chief Executive of Theranos, presented device that houses a mini spectrophotometer, a mini- to an audience of over 2500 clinical chemists and other luminometer, and mini-flow-cytometer and a mini-PCR laboratory scientists, as well as to an impressive number machine, along with a centrifuge.
    [Show full text]
  • Table of Contents
    ����������������������� �������� ������������������������� Table of Contents INTRODUCTION & OVERVIEW 2005-2006 4 HONOURS/AWARDS/APPOINTMENTS 6 Appointments 6 Awards 7 CLINICAL SERVICES 8 Patient Services 8 Clinical Biochemistry 8 Hematopathology & Blood Transfusion 9 Rapid Response Laboratory 9 Pathology 10 Laboratory Genetics 11 Andrology 12 LABORATORY INFORMATICS 13 Laboratory Information System 13 Expanded Interfaces 13 Citrix Support 13 Web Site/Communications 13 Paradigm Document Control System 14 Digital Imaging 14 RENOVATIONS & RELOCATIONS 15 QUALITY PROGRAMS 16 Accreditations, Regulatory Certifications/Registrations 16 External Quality Assessment Programs 17 Continuous Quality Improvement Activities: Indicators 18 Quality Management Team Activities: 2005-2006 18 EDUCATION 19 Educational Activities July 2005 – June 2006 19 Education Committee 19 Medical Education 19 Research Student Programs 24 Technical Education 25 SPONSORED RESEARCH AND INNOVATION 27 PRESENTATIONS & ABSTRACTS July 1, 2005 – June 30, 2006 32 SCIENTIFIC PAPERS July 1, 2005 – June 30, 2006 50 BOOKS & BOOK CHAPTERS 69 APPENDIX A - Medical and Scientific Staff as at June 30, 2006 71 APPENDIX B - Technical & Support Staff as at June 30, 2005 73 APPENDIX C - Technical & Support Staff Changes 75 APPENDIX D - Residents 76 APPENDIX E - Fellows 77 APPENDIX F - Graduate Students 2005-2006 78 APPENDIX G - Post Doctoral Students 81 APPENDIX H - Summer Students May – August 2005 82 APPENDIX I - Reportable Tests 83 APPENDIX J - External Service Linkages 85 APPENDIX K - April
    [Show full text]
  • NCI Designated Cancer Centers International Activities
    International Activities of NCI-Designated Cancer Centers Summary Report March 2014 This report is not a comprehensive summary of the international efforts of NCI-Designated Cancer Centers and not all of the efforts outlined in this report are NCI or NIH-funded. Rather, this report summarizes information that was provided by Cancer Centers who responded to requests from the NCI Center for Global Health for information on international activities. This is an ongoing data- collection effort, the data collection status for individual cancer centers can be found in Appendix A. Any additions or corrections are welcome. Please contact Rebecca Minneman ([email protected]). Table of Contents Abramson Cancer Center - University of Pennsylvania ....................................................................................4 Albert Einstein Cancer Center - Yeshiva University ..........................................................................................4 Alvin J. Siteman Cancer Center - Washington University ..................................................................................5 The Barbara Ann Karmanos Cancer Institute – Wayne State University ............................................................6 The Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio (UTHSCSA) ................................................................................................................................................... 10 Case Comprehensive Cancer Center - Case Western
    [Show full text]
  • Scientific Meeting & Clinical Lab Expo
    PROGRAM GUIDE 70TH AACC ANNUAL SCIENTIFIC MEETING & CLINICAL LAB EXPO JOIN THE GLOBAL LABORATORY MEDICINE COMMUNITY July 29–August 2, 2018 Chicago, IL USA RATI LABO ON OL C CL INICAL TORY RA BO A L M ED IC IN E CONTENTS Offices & Meeting Services ...................................................................................................................... 2 Registration Hours Clinical Lab Expo Hours AACC 2018 Mobile App AACC Shuttle Schedule & Routes ............................................................................................................ 4 Hotel Information ..................................................................................................................................... 6 2018 Supporters ...................................................................................................................................... 8 2018 Annual Meeting Organizing Committee ......................................................................................... 9 AACC Board of Directors Governance & Special Events Schedule................................................................................................. 10 Scientific Poster Sessions Schedule ....................................................................................................... 12 Division Poster Walks ............................................................................................................................. 13 DEFINE YOUR VISION Student Poster Contest .........................................................................................................................
    [Show full text]
  • Is Theranos a Tech Revolution in Healthcare Or Marketing Hype Cloaked in Secrecy? 27 January 2016, by David Glance, University of Western Australia
    Is Theranos a tech revolution in healthcare or marketing hype cloaked in secrecy? 27 January 2016, by David Glance, University Of Western Australia In part, the illusion of Theranos has been maintained by the company keeping much of how it operates a closely guarded secret. This has made it very difficult to assess the validity of both its claims and that of the growing chorus of criticism aimed at the company. Theranos claims that its uses its patented "NanotainerTM Tubes" that together with its own testing machines and software, makes running "hundreds" of tests from very small amounts of blood a possibility. This technology will allow it to offer tests at a much cheaper price than traditional testing companies and deliver the results much quicker and direct to the consumer. Elizabeth Holmes. Credit: Steve Jennings/Getty Images for TechCrunch), CC BY The critics however have taken this secrecy to signify that Theranos is hiding the real truth and that the technology has not succeeded. Instead, they believe that Theranos is largely relying on If one company were to symbolise the entire ethos much the same technology and practices as its of Silicon Valley, it would be Theranos. Founded competitors. by Elizabeth Holmes who was 19 at the time, the company set out to "reinvent" the laboratory blood The most vocal of the critics has been investigative testing industry by using "revolutionary finger-stick reporter John Carreyou of The Wall Street Journal. technology" which would make testing hundreds of In October of 2015, Carreyou first wrote about the different tests possible from blood obtained by a behind-the-scenes problems Theranos was single prick of a finger.
    [Show full text]
  • I N I T T O G E T H
    IN IT TOGETHER University Health Network 2018 Research Report Research Snapshot Researchers 1,020 Appointed Researchers 468 Non-Appointed Researchers 552 Research Space 971,794 sq. ft. Funding $383,083,710 Trainees 834 Fellows 305 Graduate Students 529 Staff 1,707 Institute Staff 1,449 Research Support Staff 258 Publications 3,519 University Health Network (UHN) is a research hospital affiliated with the University of Toronto and a member of the Toronto Academic Health Science Network (TAHSN). UHN comprises the Michener Institute for Education at UHN and four hospitals: the Princess Margaret Cancer Centre (PM Cancer Centre), Toronto General Hospital (TG), Toronto Rehab (TR) and Toronto Western Hospital (TW). It has five research institutes: Krembil Research Institute (Krembil), PM Cancer Centre, Techna Institute for the Advancement of Technology for Health (Techna), Toronto General Hospital Research Institute (TGHRI) and Toronto Rehabilitation Institute (TRI). Research is supported in part by UHN’s foundations: The Princess Margaret Cancer Foundation (PMCF), the Toronto General & Western Hospital Foundation (TGWHF) and the Toronto Rehab Foundation (TRF). The scope of research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. On the cover: The hanging origami shapes feature icons representing various disciplines and skills in research and medicine. The two-dimensional shadow cast by these shapes—‘UHN’—symbolizes how diverse skills and disciplines come together at UHN to advance health research and innovation. Table of Contents Welcome Message 2 UHN is Home to Great Places 4 Toronto General Hospital Research Institute 6 Techna Institute for Advancement of Technology for Health 16 Princess Margaret Cancer Centre 22 Toronto Rehabilitation Institute 32 Krembil Research Institute 42 UHN Foundations 51 Financials 55 Awards and Distinctions 56 Committees 58 External Sponsors 60 Trustee and Advisory Boards 63 Welcome Message Going Far Together Helping people recover from a stroke.
    [Show full text]
  • After Theranos Instruments, Leading to Errors, the Newspaper Reported
    NEWS FEATURE Erin Dewalt/Springer Nature and petite_lili/ iStock / Getty After Theranos instruments, leading to errors, the newspaper reported. The next month, the CMS inspected Theranos’ laboratory in Newark, California, and The implosion of blood diagnostics developer Theranos has raised found numerous deficiencies, some of which the question: What is feasibly detectible in a drop of blood? posed “immediate jeopardy to patient health Emily Waltz reports. and safety,” CMS said in a letter to the company (Box 1). The agency banned Holmes from running a laboratory for two years. Walgreens, which was Imagine doing a raft of diagnostic tests from a goal of measuring clinically relevant markers in hosting dozens of Theranos blood-draw sites finger prick of blood. This was the dream sold a drop of blood. in Arizona, severed its relationship with the by billion-dollar blood-testing startup Theranos. company, shuttered the sites, and in November The company claimed it could run over 200 tests Implosion sued the company. Theranos now faces multi- on a few drops of blood, while the rest of the Theranos founder Elizabeth Holmes, a well- ple fraud lawsuits, along with investigations by field was plodding along on only a few dozen connected 19-year-old Stanford University federal prosecutors and the US Securities and such tests. Unfortunately, Theranos’ claim drop-out, claimed her company, launched in Exchange Commission. turned out to be just that—a pipe dream. 2003, could do practically any diagnostic test The debacle, which came to a head in late on a few drops of blood from a finger prick.
    [Show full text]
  • Better. Faster. Stronger
    Better Performance Faster Treatment Planning Stronger Immune System BETTER. FASTER. STRONGER. Better Therapies Faster Diagnosis Stronger Hearts 2017 Research Report Health innovation at UHN Research Snapshot TOTAL RESEARCHERS 1,094 Appointed Researchers 464 Clinical Researchers 630 RESEARCH SPACE 969,913 sq. ft. TOTAL FUNDING $386,192,252 TOTAL TRAINEES 783 Fellows 309 Graduate Students 474 TOTAL STAFF 2,098 Institute Staff 1,802 Research Support Staff 296 PUBLICATIONS 3,732 The cover features six UHN researchers whose work exemplifies how we are making health care better, faster and stronger. They are, from top left (clockwise): Drs. Karen Davis, Thomas Purdie, Pamela Ohashi, Michael Laflamme, Frank Rudzicz and Cristina Nostro. University Health Network (UHN) is a research hospital affiliated with the University of Toronto and a member of the Toronto Academic Health Science Network (TAHSN). UHN comprises the Michener Institute for Education at UHN and four hospitals: the Princess Margaret Cancer Centre (PM Cancer Centre), Toronto General Hospital (TGH), Toronto Rehab (TR) and Toronto Western Hospital (TWH). It has five research institutes: Krembil Research Institute (Krembil), PM Cancer Centre, Techna Institute for the Advancement of Technology for Health (Techna), Toronto General Hospital Research Institute (TGHRI) and Toronto Rehabilitation Institute (TRI). The scope of research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. BETTER. FASTER. STRONGER. Welcome
    [Show full text]
  • Predicting Response and Toxicity to PD-1 Inhibition Using Serum Autoantibodies Identified from Immuno-Mass Spectrometry [Version 1; Peer Review: 2 Approved]
    F1000Research 2020, 9:337 Last updated: 04 DEC 2020 RESEARCH ARTICLE Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry [version 1; peer review: 2 approved] Milena Music1*, Marco Iafolla2*, Antoninus Soosaipillai3, Ihor Batruch3, Ioannis Prassas 3, Melania Pintilie4, Aaron R. Hansen2, Philippe L. Bedard2, Stephanie Lheureux2, Anna Spreafico2, Albiruni Abdul Razak2, Lillian L. Siu2, Eleftherios P. Diamandis 1,3,5,6 1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada 2Division of Medical Oncology and Hematology, University Health Network, Canada, Toronto, ON, Canada 3Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Toronto, ON, Canada 4Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Canada, Toronto, ON, Canada 5Department of Clinical Biochemistry, University Health Network, Canada, Toronto, ON, Canada 6Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Toronto, ON, Canada * Equal contributors v1 First published: 07 May 2020, 9:337 Open Peer Review https://doi.org/10.12688/f1000research.22715.1 Latest published: 07 May 2020, 9:337 https://doi.org/10.12688/f1000research.22715.1 Reviewer Status Invited Reviewers Abstract Background: Validated biomarkers are needed to identify patients at 1 2 increased risk of immune-related adverse events (irAEs) to immune checkpoint blockade (ICB). Antibodies directed against endogenous version 1 antigens can change after exposure to ICB. 07 May 2020 report report Methods: Patients with different solid tumors stratified into cohorts received pembrolizumab every 3 weeks in a Phase II trial (INSPIRE 1. Gerasimos Sykiotis , Lausanne University study). Blood samples were collected prior to first pembrolizumab exposure (baseline) and approximately 7 weeks (pre-cycle 3) into Hospital & University of Lausanne, Lausanne, treatment.
    [Show full text]